đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this observer blind study is to assess the safety in terms o...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-22
Trial ID
NCT00547248
Treatments Being Tested
This study will assess the impact on nasopharyngeal carriage, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-02-09
Trial ID
NCT01262872
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
The study aims to evaluate the safety and immunogenicity of the 10-valent a...
Status
Unknown
Location
Papua New Guinea Institute of Medical Research
Start Date
2011-11
Trial ID
NCT01619462
Treatments Being Tested
This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-07
Trial ID
NCT00344318
Treatments Being Tested
The purpose of this study is to provide critical information on the safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-04-08
Trial ID
NCT03636906
Treatments Being Tested
This is a study in a large number of healthy children less than 3 years old...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-28
Trial ID
NCT00466947
This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-13
Trial ID
NCT00970307
Treatments Being Tested
This study will evaluate the safety, reactogenicity and immunogenicity of a...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09-25
Trial ID
NCT00370396
Treatments Being Tested
The purposes of this study are: To demonstrate the immunogenicity in terms...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06-10
Trial ID
NCT00680914
Treatments Being Tested